Medical Doctor Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Tejas Shah

Pain Medicine Ashland, KY Medical Doctor

NPI 1821442849 CMS profile 8878409

617 23Rd St Ste 8B, Ashland, KY 41101

Open in the dashboard

General payments

$22,557

286 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Tejas Shah of Ashland, KY is reported in the CMS Open Payments database as having received $22,557 across 286 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 91st percentile of Pain Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $147 1
2024 General $1,059 25
2023 General $6,241 59
2022 General $9,456 153
2021 General $5,655 48

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Tejas Shah
  • Pain Medicine median
  • Middle half of Pain Medicine
  • National median

In program year 2025, general payments to Tejas Shah were reported at $147. Among 2,779 Pain Medicine profiles paid that year, the median was $458 and the middle half received between $124 and $1,401.

Show as a table
Year Tejas Shah Pain Medicine median Middle half National median
2019 $0 $498 $126–$1,682 $163
2020 $0 $284 $80–$910 $114
2021 $5,655 $399 $112–$1,219 $132
2022 $9,456 $455 $137–$1,484 $149
2023 $6,241 $484 $128–$1,495 $160
2024 $1,059 $498 $131–$1,540 $164
2025 $147 $458 $124–$1,401 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Abbott Laboratories $7,264 69 payments
  2. Medtronic, Inc. $7,072 69 payments
  3. Boston Scientific Corporation $6,790 129 payments
  4. Nevro Corp. $643 11 payments
  5. Vertos Medical, Inc. $228 2 payments
  6. BIOTRONIK NRO, Inc. $147 1 payment
  7. SPR Therapeutics, Inc $137 1 payment
  8. Nalu Medical, Inc. $125 1 payment
  9. Saluda Medical Americas, Inc. $93 1 payment
  10. Actelion Pharmaceuticals US, Inc. $36 1 payment
  11. Other $23 1 payment

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Travel and Lodging $15,233 63 payments
  2. Food and Beverage $7,324 223 payments
Products named General payments · program years 2021–2025
  1. PROCLAIM Neuromodulation $3,780 23 payments
  2. PROCLAIM Neuromodulation $3,329 39 payments
  3. WaveWriter Alpha Prime 16 $3,120 99 payments
  4. VANTA ADAPTIVESTIM $2,914 11 payments
  5. WAVEWRITER ALPHA $2,760 21 payments
  6. INTELLIS ADAPTIVESTIM $2,353 40 payments
  7. KYPHON Balloon Kyphoplasty $1,615 13 payments
  8. Superion $516 2 payments
  9. Omnia $364 7 payments
  10. Senza $278 4 payments
  11. Other $1,608 30 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

286 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pain Medicine in Kentucky

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record